Incidence and prognostic factors of clinically meaningful toxicities of kinase inhibitors in older patients with cancer: The PreToxE study
Authors:
- Coriolan LebretonCLCoriolan Lebreton
- Coralie CantarelCCCoralie Cantarel
- Emilie ToulzaETEmilie Toulza
- Romain DesgrippesRDRomain Desgrippes
- Laurence BozecLBLaurence Bozec
- Esma SaadaESEsma Saada
- Agnès DucoulombierADAgnès Ducoulombier
- Elena PaillaudElena Paillaud
- Caroline LaletCLCaroline Lalet
- Carine BelleraCBCarine Bellera
- Antoine ItalianoAntoine Italiano
- 1 May 2021
- journal article
- research article
- Published by Elsevier in Journal of Geriatric Oncology
- Vol. 12 (4) , 668-671
Abstract
No abstract availableKeywords
Funding Information
- Agence Nationale de Sécurité du Médicament et des Produits de Santé
This publication has 10 references indexed in Scilit:
- Under-reporting of harm in clinical trialsThe Lancet Oncology, 2016
- The impact of low-grade toxicity in older people with cancer undergoing chemotherapyBritish Journal of Cancer, 2014
- Polypharmacy and the management of the older cancer patientAnnals of Oncology, 2013
- Potential Medication Problems in Older Newly Diagnosed Cancer Patients in Canada during Cancer TreatmentDrugs & Aging, 2010
- Polypharmacy in older oncology patients and the need for an interdisciplinary approach to side-effect managementJournal of Clinical Pharmacy and Therapeutics, 2007
- The Effect of Ageing on Cytochrome P450 Enzymes: Consequences for Drug Biotransformation in the ElderlyCurrent Medicinal Chemistry, 2007
- The Influence of Age and Sex on the Clearance of Cytochrome P450 3A SubstratesClinical Pharmacokinetics, 2005
- Enrollment of Elderly Patients in Clinical Trials for Cancer Drug Registration: A 7-Year Experience by the US Food and Drug AdministrationJournal of Clinical Oncology, 2004
- Prospective Evaluation of Cancer Clinical Trial Accrual Patterns: Identifying Potential Barriers to EnrollmentJournal of Clinical Oncology, 2001
- Age and cytochrome P450-linked drug metabolism in humans: An analysis of 226 subjects with equal histopathologic conditions*Clinical Pharmacology & Therapeutics, 1997